博晖创新：控股子公司签订增资补充协议

Group 1 - The company announced that its subsidiary, Hebei Bohui, signed a supplementary agreement with Tongying Group regarding the approval of three blood plasma collection stations [1] - The agreement stipulates that within 24 months from the effective date of all terms, Tongying Group must complete the approval for the three plasma stations or develop new plasma stations to replace those not approved [1] - If the approvals are not completed, Hebei Bohui has the right to demand a compensation of 80 million yuan for each unapproved plasma station [1]